MEF2 is a key regulator of cognitive potential and confers resilience to neurodegeneration

Scarlett J. Barker, Ravikiran M. Raju, Noah Milman, Jun Wang, José Dávila-Velderrain, Fatima Gunter‐Rahman, Cameron Parro, P. Lorenzo Bozzelli, Fatema Abdurrob, Karim Abdelaal,

Science Translational Medicine · 2021 · 96 citations · 59 references

DOIFull text

Open access

Concepts

Abstract

in the PS19 mouse model of tauopathy and found that this was sufficient to improve cognitive flexibility and reduce hyperexcitability. Overall, our findings reveal a previously unappreciated role for MEF2 TFs in promoting CgR, highlighting their potential as biomarkers or therapeutic targets for neurodegeneration and healthy aging.

References

59